Skip to main content
Intermediate Technical IVT

Salivary Gland Hypofunction

Also written as: SGH — Salivary Gland Hypofunction

A measurable reduction in salivary output from one or more salivary glands, which may or may not be symptomatic as xerostomia.

Full Definition

Salivary gland hypofunction (SGH) is an objective clinical finding defined by specific thresholds of reduced salivary flow, typically whole unstimulated flow below 0.1 mL/min or whole stimulated flow below 0.5 mL/min. It is caused by irradiation, Sjögren's syndrome, drug side-effects, gland aplasia, or systemic disease. Critically for editors, SGH (objective reduction) and xerostomia (subjective sensation of dry mouth) are not synonymous: a patient may have reduced flow without complaint, or may complain of dryness with normal flow. Both terms appear frequently in oral medicine literature and require precise differentiation. The abbreviation SGH should be defined at first use.

Usage

Usage note: Always distinguish 'salivary gland hypofunction' (objective, measured) from 'xerostomia' (subjective, reported). Manuscripts that conflate these terms should be queried.

In Context

  • "Salivary gland hypofunction was confirmed by sialometry; however, the patient denied subjective dry mouth." — Oral medicine case note
  • "The systematic review used 'xerostomia' and 'salivary gland hypofunction' interchangeably, which the editor flagged as a methodological inconsistency." — Systematic review editorial query

Also known as

SGH salivary hypofunction

Contrasted with

sialorrhoea hypersalivation

Don't confuse with

xerostomia hyposalivation

Editors from these organisations have used our services since 1998

Reuters BBC Oxford University Press Penguin Random House Springer Microsoft Suncor Energy United Nations Fisher Investments IBM The Home Depot KODAK CHEVRON